A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseCognitive dysfunction and dementia in Parkinson diseaseCholinesterase inhibitors for Parkinson's disease dementiaMeta-analysis of risk factors for Parkinson's disease dementiaAn Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with DementiaSex Differences in Clinical Features of Early, Treated Parkinson's Disease.The spectrum of cognitive disorders in Parkinson's disease: a data-driven approach.Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease.How to diagnose dementia with Lewy bodies: state of the art.Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease DementiaAssociation of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.The epidemiology of dementia associated with Parkinson's disease.An update on brain imaging in parkinsonian dementiaNonmotor complications in Parkinson's disease.Depression in Parkinson's disease -- a review.Predictors of cognitive impairment in an early stage Parkinson's disease cohortCharacteristics of language impairment in Parkinson's disease and its influencing factorsCognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects.Cognitive impairment in Parkinson's disease.Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group.Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia.CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson DiseaseAltered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer diseaseMMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up studyTreatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.'When did my tremor start?': can essential tremor patients pinpoint their disease onset?Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.Depression in Parkinson's disease: health risks, etiology, and treatment options.Clinical diagnostic criteria for dementia associated with Parkinson's disease.Differential effects of duration and age on the consequences of neuroinflammation in the hippocampusCognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease.Brain amyloid and cognition in Lewy body diseases.Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.Mild cognitive impairment in Parkinson's disease: the challenge and the promiseRivastigmine in Parkinson's disease dementia.
P2860
Q21131066-2DAB0AE0-EF8E-4942-A0DF-16B1012288F4Q22252885-2D5429C6-41DA-49B3-9C2D-A542D3743DB6Q24244668-21A0C518-450C-4E44-A811-23BABD04383DQ26743404-A1F6C486-5F5B-4A36-A040-AEB010739AB4Q28552902-DE5DD1BA-B897-41C7-AE30-143F1C910585Q30375563-7EDF2C6D-0F80-47BD-BB88-608452F2E748Q30593620-B2878929-22A6-4E54-9F9D-FA4F456DFBEAQ30920732-89AF3710-0F7A-45DB-A2BF-92AF0604C962Q30999035-A7A775A4-732E-41C8-A6CA-48678C78EB93Q33159140-67E34C1A-B2AC-4B64-9946-FE1FA9043899Q33562458-F01E1F19-8FD4-4B37-A4EC-303E11AACBD5Q33666297-21275857-1F7B-451C-9F54-52D1EA05BCAAQ34118948-F6378528-7C86-49D9-A2CB-1D1D36812F71Q34327937-7C614453-4CD8-4118-99C3-EEEB57353725Q34410401-17220685-65AD-45AE-B319-AFBD36B06907Q34478301-D56A64BB-5AD3-4CC2-86B7-6D2B54AB8EADQ34531319-64B30843-65FD-49B6-B20C-77F9E990BA27Q35083853-B79E97B3-CF85-408C-8503-39447E931F1AQ35988441-ABAD6553-9562-477F-862E-A27B0FF49243Q36135045-52D82D13-ED99-4D3E-A3B8-BA844CB912A0Q36226772-1F8C7CF2-A751-4FFC-ABFB-2B3B4C7604F8Q36279999-C5D3CA90-23C0-4E21-B035-FCF2F2F46AE1Q36407197-72B9907F-E70A-44FE-B635-61A4754DB0DBQ36475260-B10C26FF-37AF-46AB-A8CF-ADD06CC141E0Q36480203-F1166D0A-3EEA-4BA2-B8AF-EB184EFFD2B9Q36535217-9C40A666-E251-4C7E-B861-629F54E96872Q36545671-EA5B3F05-FD69-486F-9304-7D41C299DE9AQ36763084-1EB809E2-62E9-427E-891D-991B32AE631AQ36772321-A347129E-3685-474A-B2DC-F75266667147Q36775208-B60FC6A6-7888-423A-A975-B32C55C7494CQ36812559-BA703CF2-6D93-4B27-8CD4-DDC09EE742B9Q36834550-50A04923-BD07-443F-B6D9-1B47E9940020Q36836774-AAA29367-693B-41CD-B897-B4A75FB8BD4DQ36836828-627CA592-BD58-4100-B9CA-790F7A8B0991Q36997011-E21A4F78-E2F6-4579-B5E7-5BF43B80B5DFQ37039444-5683DAA3-F3DD-49E6-9914-60354E05BB93Q37050071-54F48004-D202-47F8-9C20-4CC199D840ABQ37103264-D561D637-1EF8-4E8D-8501-E1F0DC12F589Q37196144-C2BADC56-4823-40C3-B6AB-8C209CD13E11Q37232006-9324A74D-C666-405E-B9C7-E183E5A61C0B
P2860
A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A 10-year study of the inciden ...... mentia in Parkinson's disease.
@en
A 10-year study of the inciden ...... mentia in Parkinson's disease.
@nl
type
label
A 10-year study of the inciden ...... mentia in Parkinson's disease.
@en
A 10-year study of the inciden ...... mentia in Parkinson's disease.
@nl
prefLabel
A 10-year study of the inciden ...... mentia in Parkinson's disease.
@en
A 10-year study of the inciden ...... mentia in Parkinson's disease.
@nl
P2093
P356
P1433
P1476
A 10-year study of the inciden ...... mentia in Parkinson's disease.
@en
P2093
P304
P356
10.1212/WNL.54.8.1596
P407
P577
2000-04-01T00:00:00Z